Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ethicon Endo-Surgery, a Johnson & Johnson company, has entered into a definitive agreement to acquire SurgRx, a privately held developer of the advanced bipolar tissue sealing system used in the EnSeal family of devices.
Subscribe to our email newsletter
Ethicon Endo-Surgery said that the acquisition will provide the company with a new energy platform, which complements its Harmonic line of ultrasonic medical devices that have been used to perform open and laparoscopic procedures worldwide.
Terms of the agreement were not disclosed. The transaction is subject to customary clearances, including the Hart-Scott-Rodino Antitrust Improvements Act and similar regulations in other countries.
Karen Licitra, group chairman and worldwide franchise chairman of Ethicon Endo-Surgery, said: Ethicon Endo-Surgery and SurgRx share a commitment to innovation for the surgeons and patients who depend on our products. Together, the combination of Harmonic and EnSeal technologies will position us to better address many different procedure needs.